These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 30662960)
1. TRPC6 inactivation does not affect loss of renal function in nephrotoxic serum glomerulonephritis in rats, but reduces severity of glomerular lesions. Kim EY; Shotorbani PY; Dryer SE Biochem Biophys Rep; 2019 Mar; 17():139-150. PubMed ID: 30662960 [TBL] [Abstract][Full Text] [Related]
2. Effects of TRPC6 Inactivation on Glomerulosclerosis and Renal Fibrosis in Aging Rats. Kim EY; Dryer SE Cells; 2021 Apr; 10(4):. PubMed ID: 33918778 [TBL] [Abstract][Full Text] [Related]
3. Trpc6 inactivation confers protection in a model of severe nephrosis in rats. Kim EY; Yazdizadeh Shotorbani P; Dryer SE J Mol Med (Berl); 2018 Jul; 96(7):631-644. PubMed ID: 29785489 [TBL] [Abstract][Full Text] [Related]
4. TRPC6 Inactivation Reduces Albuminuria Induced by Protein Overload in Sprague Dawley Rats. Kim EY; Dryer SE Cells; 2022 Jun; 11(13):. PubMed ID: 35805070 [TBL] [Abstract][Full Text] [Related]
5. TRPC6 inactivation does not protect against diabetic kidney disease in streptozotocin (STZ)-treated Sprague-Dawley rats. Hassanzadeh Khayyat N; Kim EY; Dryer SE FASEB Bioadv; 2019 Dec; 1(12):773-782. PubMed ID: 32123821 [TBL] [Abstract][Full Text] [Related]
6. Renal Fibrosis, Immune Cell Infiltration and Changes of TRPC Channel Expression after Unilateral Ureteral Obstruction in Trpc6-/- Mice. Kong W; Haschler TN; Nürnberg B; Krämer S; Gollasch M; Markó L Cell Physiol Biochem; 2019; 52(6):1484-1502. PubMed ID: 31099508 [TBL] [Abstract][Full Text] [Related]
7. Huangkui Capsule Ameliorates Renal Fibrosis in a Unilateral Ureteral Obstruction Mouse Model Through TRPC6 Dependent Signaling Pathways. Gu LF; Ge HT; Zhao L; Wang YJ; Zhang F; Tang HT; Cao ZY; Yu BY; Chai CZ Front Pharmacol; 2020; 11():996. PubMed ID: 32719603 [TBL] [Abstract][Full Text] [Related]
8. TRPC channels: Regulation, dysregulation and contributions to chronic kidney disease. Dryer SE; Roshanravan H; Kim EY Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1041-1066. PubMed ID: 30953689 [TBL] [Abstract][Full Text] [Related]
9. Antibody blockade of TNF-alpha reduces inflammation and scarring in experimental crescentic glomerulonephritis. Khan SB; Cook HT; Bhangal G; Smith J; Tam FW; Pusey CD Kidney Int; 2005 May; 67(5):1812-20. PubMed ID: 15840028 [TBL] [Abstract][Full Text] [Related]
10. Changes in podocyte TRPC channels evoked by plasma and sera from patients with recurrent FSGS and by putative glomerular permeability factors. Kim EY; Roshanravan H; Dryer SE Biochim Biophys Acta Mol Basis Dis; 2017 Sep; 1863(9):2342-2354. PubMed ID: 28629718 [TBL] [Abstract][Full Text] [Related]
11. TRPC Channels in Proteinuric Kidney Diseases. Hall G; Wang L; Spurney RF Cells; 2019 Dec; 9(1):. PubMed ID: 31877991 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of TRPC6 channels ameliorates renal fibrosis and contributes to renal protection by soluble klotho. Wu YL; Xie J; An SW; Oliver N; Barrezueta NX; Lin MH; Birnbaumer L; Huang CL Kidney Int; 2017 Apr; 91(4):830-841. PubMed ID: 27979597 [TBL] [Abstract][Full Text] [Related]
13. Piperlonguminine attenuates renal fibrosis by inhibiting TRPC6. Zhou L; Wu K; Gao Y; Qiao R; Tang N; Dong D; Li XQ; Nong Q; Luo DQ; Xiao Q; Fan X; Duan Q; Cao W J Ethnopharmacol; 2023 Sep; 313():116561. PubMed ID: 37121453 [TBL] [Abstract][Full Text] [Related]
15. Low-dose local kidney irradiation inhibits progression of experimental crescentic nephritis by promoting apoptosis. Liu D; Nazneen A; Taguchi T; Razzaque MS Am J Nephrol; 2008; 28(4):555-68. PubMed ID: 18239382 [TBL] [Abstract][Full Text] [Related]
16. A mutation in TRPC6 channels abolishes their activation by hypoosmotic stretch but does not affect activation by diacylglycerol or G protein signaling cascades. Wilson C; Dryer SE Am J Physiol Renal Physiol; 2014 May; 306(9):F1018-25. PubMed ID: 24598806 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic effect of all-trans retinoic acid on rats with anti-GBM antibody glomerulonephritis. Oseto S; Moriyama T; Kawada N; Nagatoya K; Takeji M; Ando A; Yamamoto T; Imai E; Hori M Kidney Int; 2003 Oct; 64(4):1241-52. PubMed ID: 12969142 [TBL] [Abstract][Full Text] [Related]
18. Anti-renal fibrosis effect of asperulosidic acid via TGF-β1/smad2/smad3 and NF-κB signaling pathways in a rat model of unilateral ureteral obstruction. Xianyuan L; Wei Z; Yaqian D; Dan Z; Xueli T; Zhanglu D; Guanyi L; Lan T; Menghua L Phytomedicine; 2019 Feb; 53():274-285. PubMed ID: 30668407 [TBL] [Abstract][Full Text] [Related]
19. Regulation of TRPC6 ion channels in podocytes - Implications for focal segmental glomerulosclerosis and acquired forms of proteinuric diseases. Szabó T; Ambrus L; Zákány N; Balla G; Bíró T Acta Physiol Hung; 2015 Sep; 102(3):241-51. PubMed ID: 26551740 [TBL] [Abstract][Full Text] [Related]
20. Danggui Buxue Tang Attenuates Tubulointerstitial Fibrosis via Suppressing NLRP3 Inflammasome in a Rat Model of Unilateral Ureteral Obstruction. Wang L; Ma J; Guo C; Chen C; Yin Z; Zhang X; Chen X Biomed Res Int; 2016; 2016():9368483. PubMed ID: 27872860 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]